A Prospective, Open-Labelled, Non-Controlled Observation to Assess Doctor Preference on FlexPenTM for Treatment of Diabetes Mellitus
Philippine Journal of Internal Medicine · 2009
DOI: 10.3860/pjim.v47i1.883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Philippine Journal of Internal Medicine, 2009. Verfasst von Teresa Plata-Que und 6 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The accuracy and convenience of pen devices for insulin injection have improved quality of life for patients with insulin-treated diabetes mellitus (DM). Prefilled, disposable pens have the advantage of simplicity, with minimal training and attention required and these offer improvements in compliance, freedom and flexibility.
Objective
The survey assessed doctor preference in prescribing insulin in a FlexPen™ in diabetes patients in the Philippines under normal clinical practice conditions. The data was based from observations on the use of NovoMix® 30 FlexPen™ (Biphasic Insulin Aspart 30). Data was collected from 256 doctors who were specialised in treating patients with diabetes and had their clinics in the Philippines. A Doctor Preference Questionnaire was developed to assess doctor preference in specific terms of ease of learning and teaching use of FlexPen™, time spent for patient training in use of FlexPen™, ease of setting up the required dose of FlexPen™, DoctorEs satisfaction of shifting from any other device to FlexPen™, confidence that the correct amount of insulin will be injected, feedback about the NovoFine® 30G needles, overall experience with FlexPen™.
Results
In total, 256 doctors participated and completed the doctor satisfaction questionnaires. Majority of doctors 62.1% felt learning/ teaching the use of FlexPen™ to the patients was „very easy‰; and 66.8% healthcare professionals (doctor or their staff) spent less than 10 minutes to train the patients on how to use FlexPen™. About 96% doctors responded that it is very easy or easy to set up the required dose and dose correction using FlexPen™. About (98.8%) doctors were confident or very confident that their patients will inject the correct dosage of insulin using FlexPen™. Almost all doctors (98.4%) satisfied or very satisfied about the patient shifting from other insulin devices to FlexPen™; 39.5% doctors rated the design of FlexPen™ as excellent; 55.5% rated it as good; while 74.6% doctors rated the overall experience of FlexPen™ as excellent.
Conclusion
The participating doctors showed high degree of acceptance of Flexpen™. The overall experience of Flexpen™ was excellent.
Zitieren
APA
Plata-Que, T., Fernando, R. E., Raboca, J., Sobrepeña, L., Sy, R. A., Yu-Gan, S., & Arceo-Dalisay, E. (2009). A Prospective, Open-Labelled, Non-Controlled Observation to Assess Doctor Preference on FlexPenTM for Treatment of Diabetes Mellitus. Philippine Journal of Internal Medicine. https://doi.org/10.3860/pjim.v47i1.883
Vancouver
Plata-Que T, Fernando RE, Raboca J, Sobrepeña L, Sy RA, Yu-Gan S, et al. A Prospective, Open-Labelled, Non-Controlled Observation to Assess Doctor Preference on FlexPenTM for Treatment of Diabetes Mellitus. Philippine Journal of Internal Medicine. 2009. doi:10.3860/pjim.v47i1.883
BibTeX
@article{PlataQue2009,
author = {Plata-Que, Teresa and Fernando, Richard Elwyn and Raboca, Josephine and Sobrepeña, Leorino and Sy, Rosa Allyn and Yu-Gan, Susan and Arceo-Dalisay, Editha},
title = {A Prospective, Open-Labelled, Non-Controlled Observation to Assess Doctor Preference on FlexPenTM for Treatment of Diabetes Mellitus},
journal = {Philippine Journal of Internal Medicine},
year = {2009},
doi = {10.3860/pjim.v47i1.883}
}
EUVIMED